S. A. Wiseman
Charing Cross Hospital
9 Papers
331 Citations
S. A. Wiseman is an academic researcher from Charing Cross Hospital. The author has contributed to research in topics: Coronary artery disease & Carotid artery disease. The author has an hindex of 7, co-authored 9 publications.
Chat about Author
Papers
Influence of smoking and plasma factors on patency of femoropopliteal vein grafts.
S. A. Wiseman,Glenda Kenchington,R. Dain,C. E. Marshall,C N McCollum,Roger M. Greenhalgh,Janet T. Powell +6 more
TL;DR: A more forceful approach is needed to stop patients smoking; therapeutic measures to improve patency of vein grafts should focus on decreasing plasma fibrinogen concentration rather than serum cholesterol concentration.
144
DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease.
M. V. Monsalve,R. Young,J. Jobsis,S. A. Wiseman,S. Dhamu,Janet T. Powell,Roger M. Greenhalgh,Steve E. Humphries +7 more
TL;DR: Variation at the apo B locus is one of the factors involved in predisposing an individual to develop arterial disease but does not determine where in the arterial system the disease develops.
83
The influence of smoking and plasma factors on prosthetic graft patency.
S. A. Wiseman,Janet T. Powell,Roger M. Greenhalgh,Charles McCollum,Glenda Kenchington,Christine Alexander,Minder Sian,Peter Franks +7 more
TL;DR: The plasma risk factors associated with the failure of prosthetic grafts are similar to those associated withThe failure of saphenous vein grafts, indicating that higher fibrinogen levels and smoking may contribute to an hypercoagulable state.
37
Influence of apolipoproteins on the anatomical distribution of arterial disease.
TL;DR: Investigation in patients presenting with atherosclerotic disease in the carotid or peripheral arteries before the age of 50 years found genetic variation at two polymorphic sites in the apolipoprotein AI-CIII-AIV gene cluster was associated with differences in triglyceride levels.
27
Study of DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in patients with peripheral arterial disease
M. V. Monsalve,R. Young,S. A. Wiseman,S. Dhamu,Janet T. Powell,Roger M. Greenhalgh,Steve E. Humphries +6 more
TL;DR: Variation in the apolipoprotein AI-CIII-AIV gene cluster may not be contributing significantly to the development of peripheral arterial disease, but variation associated with some of the restriction fragment length polymorphisms may be involved in determining levels of cholesterol- and apoledipoprotein-B-containing lipoproteins.
22